Business
WELL Health Reports Record FY2025 Results; Canadian Patient Services Adjusted EBITDA Up 43% with Record Free Cash Flow
WELL achieved record annual revenue of $1.40 billion in 2025, an increase of 52% compared to the ...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"WELL Health Reports Record FY2025 Results; Canadian Patient Services Adjusted EBITDA Up 43% with Record Free Cash Flow\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwalignr { text-align: right; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }\n.bwpadb3 { padding-bottom: 4px }\n.bwpadl0 { padding-left: 0px }\n.bwpadl3 { padding-left: 15px }\n.bwpadr0 { padding-right: 0px }\n.bwsinglebottom { border-bottom: solid black 1pt }\n.bwtablemarginb { margin-bottom: 10px }\n.bwvertalignb { vertical-align: bottom }\n.bwwidth100 { width: 100% }\n.bwwidth14 { width: 14% }\n.bwwidth30 { width: 30% }\n \n\n\n\n\n WELL achieved record annual revenue of $1.40 billion in 2025, an increase of 52% compared to the prior year. This growth was mainly driven by acquisitions, organic growth and the inclusion of HEALWELL results in WELL’s consolidated financial reporting. WELL achieved record Adjusted EBITDA\n \n (1)\n \n of $203.7 million in 2025, an increase of 336% compared to $46.7 million in 2024, representing Adjusted EBITDA\n \n (1)\n \n margin of 14.5%.\n \n\n Excluding Circle Medical (“CM”) and CRH Medical Corporation (“CRH”) related one-time events from both FY 2025 and 2024, normalized\n \n (2)\n \n revenue would have reached $1.35 billion in 2025, representing a 34% increase compared to the previous year, while Adjusted EBITDA\n \n (1)\n \n would have been $148.6 million in 2025, representing 17% YoY growth.\n \n\n Canadian Patient Services revenue increased 39% to $444.3 million and Adjusted EBITDA\n \n (1)\n \n increased 43% to $58.1 million in 2025, driven by acquisitions and organic growth of 13% for the Canadian Patient Services business.\n \n\n WELL achieved record Operating Free Cash Flow Attributable to Shareholders or “FCFA2S”⁽¹⁾ in 2025 of $58.2 million representing an increase of approximately 19% as compared to $48.9 million in 2024.\n \n\n WELL is pleased to provide a positive outlook for 2026 with annual guidance for revenue of between $1.55 billion to $1.65 billion, and Adjusted EBITDA\n \n (1)\n \n in the range of $175 million to $185 million. The annual guidan...